Scarica l'app Stockscreener
1.31
10.08%
0.12
Dopo l'orario di chiusura:
1.31
Precedente Chiudi:
$1.19
Aprire:
$1.21
Volume 24 ore:
1.45M
Relative Volume:
2.27
Capitalizzazione di mercato:
$127.29M
Reddito:
$11.03M
Utile/perdita netta:
$-44.24M
Rapporto P/E:
-2.1129
EPS:
-0.62
Flusso di cassa netto:
$-42.61M
1 W Prestazione:
+9.17%
1M Prestazione:
+23.58%
6M Prestazione:
+21.30%
1 anno Prestazione:
+32.58%
Intervallo 1D:
$1.19
$1.37
Intervallo di 1 settimana:
$1.16
$1.37
Portata 52W:
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Nome
Hyperfine Inc
Settore
Industria
Telefono
866-796-6767
Indirizzo
351 NEW WHITFIELD STREET, GUILFORD
Confronta HYPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.31 | 115.63M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | Iniziato | Evercore ISI | Outperform |
| 2022-04-14 | Iniziato | Wells Fargo | Overweight |
Hyperfine Inc Borsa (HYPR) Ultime notizie
Hyperfine’s portable MRI shows promise in detecting small strokes By Investing.com - Investing.com Canada
Hyperfine’s portable MRI shows promise in detecting small strokes - Investing.com
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities - The AI Journal
Quarterly Earnings: Is Hyperfine Inc stock showing strong momentum2025 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 87% over the last five years - Yahoo Finance
Hyperfine’s portable brain MRI shows high concordance with standard MRI By Investing.com - Investing.com Nigeria
Study Shows Economic Benefits of Swoop System Use in Acute Hospital Care - Medical Product Outsourcing
Quarterly Risk: Is Hyperfine Inc affected by consumer sentimentOptions Play & Real-Time Sentiment Analysis - baoquankhu1.vn
Growth Review: Is Hyperfine Inc gaining market shareTrade Performance Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Institution Moves: How does ALEX perform in inflationary periodsJuly 2025 Selloffs & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics - 01net
Insider Trends: Is Hyperfine Inc affected by consumer sentimentMarket Activity Recap & Fast Gain Stock Tips - baoquankhu1.vn
Hyperfine’s portable brain MRI shows high concordance with standard MRI - Investing.com
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Up 29.5% in December - MarketBeat
Market Trends: Is KRRO currently under institutional pressure2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
Energy Moves: How does Hyperfine Inc score in quality rankings2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
Hyperfine Enrolls 1st Patient in Contrast PMR Study - Medical Product Outsourcing
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Sahm
Hyperfine begins clinical study for contrast-enhanced portable MRI By Investing.com - Investing.com Nigeria
Hyperfine Enrolls First Patient in Contrast-Enhanced Portable MRI Study - marketscreener.com
Hyperfine, Inc. Announces Enrollment of First Patient in Study to Expand Intended Use of Swoop System with Contrast Agents - marketscreener.com
Hyperfine begins clinical study for contrast-enhanced portable MRI - Investing.com
Hyperfine announces enrollment of first patient in study to expand intended use of the Swoop® system with contrast agents - marketscreener.com
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents - The AI Journal
Revenues Tell The Story For Hyperfine, Inc. (NASDAQ:HYPR) As Its Stock Soars 34% - simplywall.st
Treasury Yields: Is Hyperfine Inc stock showing strong momentumJuly 2025 Volume & Fast Moving Stock Watchlists - baoquankhu1.vn
Hyperfine announces workforce reduction to streamline operations - MSN
Indian Regulators Approve Hyperfine’s Swoop System - Medical Product Outsourcing
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 - Investing.com Canada
Hyperfine Announces Strong Preliminary Q4 2025 Revenue Growth - The Globe and Mail
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 By Investing.com - Investing.com South Africa
Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M - TipRanks
Health tech firm Hyperfine prelim Q4 revenue rises 127% on Swoop system adoption - TradingView — Track All Markets
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Published on: 2026-01-10 20:32:17 - Улправда
Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence - MSN
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - FinancialContent
Can Hyperfine Inc. stock maintain growth trajectoryCEO Change & Safe Entry Trade Signal Reports - ulpravda.ru
Is Hyperfine Inc. stock attractive for long term wealth buildingWeekly Trade Review & Daily Entry Point Trade Alerts - ulpravda.ru
Is Hyperfine Inc. stock supported by strong cash flowsWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - ulpravda.ru
Hyperfine (HYPR) Price Target Increased by 20.00% to 1.73 - MSN
How Hyperfine Inc. stock valuations compare to rivalsAutomated Trading Signals & Analyze Your Portfolio Risk in Seconds - Улправда
Can Hyperfine Inc. stock hit analyst price targets2026 world cup usa national team quarterfinals goalkeepers high defensive line odds analysis insights - ulpravda.ru
Star TribuneHyperfine, Inc.Class A Common Stock (Nasdaq:HYPR) Price Chart - FinancialContent
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care - 01net
Portable MRI system shows economic benefits for hospitals By Investing.com - Investing.com South Africa
Hyperfine, Inc. Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop®? Ai-Powered Portable Mri System in Acute Hospital Care - marketscreener.com
The Truth About Hyperfine Inc: Tiny Stock, Huge Hype – Is HYPR the Next Sleeper Moonshot? - AD HOC NEWS
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Down 15.6% in December - MarketBeat
Hyperfine Inc Azioni (HYPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):